This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
Precision medicine for patients with co-existent ovarian and endometrial cancer: the COMPARE trial
Clonal hematopoiesis as a biomarker of poor prognosis in high-grade serous ovarian cancer
Enabling a Phase I Clinical Trial of a Novel CAR-T Cell Therapy for Ovarian Cancer
Development and characterization of humanized patient-derived xenograft models for ovarian cancer
Investigating the proteome and secretome of ovarian cancer to inform early detection and treatment
Uncovering targetable interactions of ovarian cancer cells
Uncovering novel metabolic regulators of T cell function
Exploring the role of PARG in DNA repair and cancer
Investigating how a novel glycolipid drug kills chemotherapy-resistant ovarian cancer
A new approach to sustained, local, immunotherapy for ovarian cancer
